[HTML][HTML] The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono, T Eckmanns… - … Resistance & Infection …, 2020 - Springer
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

[HTML][HTML] The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono… - … and Infection Control, 2020 - ncbi.nlm.nih.gov
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.

O Ayobami, N Willrich, B Suwono… - … & Infection Control, 2020 - search.ebscohost.com
Background: Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono… - Antimicrobial …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

[PDF][PDF] The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono, T Eckmanns… - 2020 - scholar.archive.org
Background: Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

[PDF][PDF] The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono, T Eckmanns… - 2020 - researchgate.net
Background: Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

[HTML][HTML] The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono… - Antimicrobial …, 2020 - aricjournal.biomedcentral.com
Due to limited therapeutic options and their association with high mortality and morbidity,
carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public health …

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

O Ayobami, N Willrich, B Suwono… - Antimicrobial …, 2020 - search.proquest.com
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.

O Ayobami, N Willrich, B Suwono… - … and Infection Control, 2020 - europepmc.org
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.

O Ayobami, N Willrich, B Suwono… - … and Infection Control, 2020 - go.gale.com
Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …